Caroline Baumal
Chief Tech/Sci/R&D Officer at APELLIS PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Caroline Baumal is currently the Chief Medical Officer at Apellis Pharmaceuticals, Inc. and a Professor at New England Eye Center.
She holds a doctorate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-15 | 58,376 ( 0.05% ) | 3 M $ | 2024-03-30 |
Caroline Baumal active positions
| Companies | Position | Start |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2023-01-02 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Caroline Baumal
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Caroline Baumal
